Veristat launched InStat, a fully automated biostatistics platform aimed at compressing clinical trial data readout timelines from weeks to days. The software is designed to deliver submission-ready tables, listings, and figures in five days or less by converting biostatisticians’ specifications into executable outputs using validated statistical engines. The company said its first sponsor user, Clene Nanomedicine, used InStat for NfL biomarker analyses supporting an accelerated approval pathway under Subpart H for its CNM-Au8 program. Veristat also described secure portal support for real-time collaboration to reduce iteration cycles.